156 related articles for article (PubMed ID: 9042615)
1. Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors.
Newman-Tancredi A; Audinot-Bouchez V; Gobert A; Millan MJ
Eur J Pharmacol; 1997 Jan; 319(2-3):379-83. PubMed ID: 9042615
[TBL] [Abstract][Full Text] [Related]
2. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
3. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL
J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
[TBL] [Abstract][Full Text] [Related]
4. [35S]GTPgammaS binding at the human dopamine D4 receptor variants hD4.2, hD4.4 and hD4.7 following stimulation by dopamine, epinephrine and norepinephrine.
Czermak C; Lehofer M; Liebmann PM; Traynor J
Eur J Pharmacol; 2006 Feb; 531(1-3):20-4. PubMed ID: 16423344
[TBL] [Abstract][Full Text] [Related]
5. Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor.
Patel S; Freedman S; Chapman KL; Emms F; Fletcher AE; Knowles M; Marwood R; Mcallister G; Myers J; Curtis N; Kulagowski JJ; Leeson PD; Ridgill M; Graham M; Matheson S; Rathbone D; Watt AP; Bristow LJ; Rupniak NM; Baskin E; Lynch JJ; Ragan CI
J Pharmacol Exp Ther; 1997 Nov; 283(2):636-47. PubMed ID: 9353380
[TBL] [Abstract][Full Text] [Related]
6. Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors.
Newman-Tancredi A; Cussac D; Audinot V; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):447-53. PubMed ID: 10431754
[TBL] [Abstract][Full Text] [Related]
7. Epinephrine and norepinephrine act as potent agonists at the recombinant human dopamine D4 receptor.
Lanau F; Zenner MT; Civelli O; Hartman DS
J Neurochem; 1997 Feb; 68(2):804-12. PubMed ID: 9003072
[TBL] [Abstract][Full Text] [Related]
8. Characterization of dopaminergic compounds at hD2short, hD4.2 and hD4.7 receptors in agonist-stimulated [35S]GTPgammaS binding assays.
Gilliland SL; Alper RH
Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):498-504. PubMed ID: 10832603
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the mechanism of agonist and inverse agonist action at D2 dopamine receptors.
Roberts DJ; Lin H; Strange PG
Biochem Pharmacol; 2004 May; 67(9):1657-65. PubMed ID: 15081865
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a novel iodinated ligand, IPMPP, for human dopamine D4 receptors expressed in CHO cells.
Kung MP; Stevenson DA; Zhuang ZP; Vessotskie JM; Chumpradit S; Sun XM; Kung HF
Life Sci; 1997; 60(2):91-100. PubMed ID: 9000114
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the functional activity of dopamine ligands at human recombinant dopamine D4 receptors.
Chabert C; Cavegn C; Bernard A; Mills A
J Neurochem; 1994 Jul; 63(1):62-5. PubMed ID: 7911513
[TBL] [Abstract][Full Text] [Related]
12. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
[TBL] [Abstract][Full Text] [Related]
13. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
[TBL] [Abstract][Full Text] [Related]
14. Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D4 receptor.
Gazi L; Schoeffter P; Nunn C; Croskery K; Hoyer D; Feuerbach D
Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):555-64. PubMed ID: 10832611
[TBL] [Abstract][Full Text] [Related]
15. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.
Malmberg ; Mikaels ; Mohell N
J Pharmacol Exp Ther; 1998 Apr; 285(1):119-26. PubMed ID: 9536001
[TBL] [Abstract][Full Text] [Related]
16. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH
Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032
[TBL] [Abstract][Full Text] [Related]
17. Serotonergic agonists behave as partial agonists at the dopamine D2 receptor.
Rinken A; Ferré S; Terasmaa A; Owman C; Fuxe K
Neuroreport; 1999 Feb; 10(3):493-5. PubMed ID: 10208577
[TBL] [Abstract][Full Text] [Related]
18. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.
Millan MJ; Cussac D; Gobert A; Lejeune F; Rivet JM; Mannoury La Cour C; Newman-Tancredi A; Peglion JL
J Pharmacol Exp Ther; 2004 Jun; 309(3):903-20. PubMed ID: 14978194
[TBL] [Abstract][Full Text] [Related]
19. D4 dopamine receptor-mediated phospholipid methylation and its implications for mental illnesses such as schizophrenia.
Sharma A; Kramer ML; Wick PF; Liu D; Chari S; Shim S; Tan W; Ouellette D; Nagata M; DuRand CJ; Kotb M; Deth RC
Mol Psychiatry; 1999 May; 4(3):235-46. PubMed ID: 10395213
[TBL] [Abstract][Full Text] [Related]
20. Use of radiolabeled antagonist assays for assessing agonism at D2 and D3 dopamine receptors: comparison with functional GTPγS assays.
Zhen J; Antonio T; Ali S; Neve KA; Dutta AK; Reith ME
J Neurosci Methods; 2015 Jun; 248():7-15. PubMed ID: 25840364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
